Wisdom Teeth Removal can Lead to Teasing and Unwanted Nicknames

As has been covered before on teethremoval.com, one complication that can and has occured during wisdom teeth removal is the possibility of a thermal burn on the face and a permanent scar. See the wisdom teeth removal complications page for more information. As part of the nice deadly dentistry piece by The Dallas Morning News, a case of this occurring to a young woman in California is highlighted. The story is from Brooks Egerton titlted “Beating the System: Nevada disciplined dentist for deaths, but it didn’t matter in Texas,” and written December 9, 2015. The case is of a young woman entering her senior year of high school who was scheduled to have four wisdom teeth extracted in July 2008. The woman was accompanied by her mother during the procedure as is typical in many cases and then was brought out … Read more

What to Ask the Dentist Before Children Have Sedation

In July of 2017, Today ran a nice piece titled “9 questions to ask your dentist before your kids go under sedation,” written by Linda Caroll, July 10, 2017. The article discusses some recent children dental deaths that occurred in the last few years. If you have been on teethremoval.com before, you know that many cases like these have been covered in the past and you can see more on http://www.teethremoval.com/death.html and http://www.teethremoval.com/dental_deaths.html. The article says that doctors from the American Academy of Pediatrics are speaking out about the dangers of sedating children for oral surgery. It is said that it is unclear how many children or adults for that matter, have died in the U.S. during dental procedures. However, some work by the Dallas Morning News in 2015, indicates a dental patient dies nearly every other day in the U.S. The state … Read more

Fremanezumab Phase III Migraine Trial

Fremanezumab is a drug being developed by Teva Pharmaceuticals for the prevention of migraine. Fremanezumab is a monocolonal antibody and a biological agent that binds to and blocks the action of a migraine-associated protein called calcitonin gene-related peptide (CGRP).  Results of the phase III clinical trial were published in Nov., 2017, in the New England Journal of Medicine. This study showed that fremanezumab was found successful in reducing the number of days that chronic migraine sufferers experienced headaches. It is estimated that between 127 and 300 million people in the entire world experience chronic migraine, with 15 or more headaches per month for at least three months. Those who experience such intense and chronic migraines have a tough time finding effective relief. As such fremanezumab has been developed to hopefully help those who suffer and do not have any current medication that is effective. … Read more